MUGELLINI, AMEDEO
 Distribuzione geografica
Continente #
NA - Nord America 8.985
AS - Asia 7.350
EU - Europa 6.519
SA - Sud America 716
AF - Africa 185
Continente sconosciuto - Info sul continente non disponibili 12
OC - Oceania 8
Totale 23.775
Nazione #
US - Stati Uniti d'America 8.797
CN - Cina 4.026
SG - Singapore 1.656
IE - Irlanda 1.169
DE - Germania 1.070
UA - Ucraina 1.024
FI - Finlandia 907
IT - Italia 662
HK - Hong Kong 597
VN - Vietnam 518
BR - Brasile 505
RU - Federazione Russa 481
SE - Svezia 424
FR - Francia 336
GB - Regno Unito 213
IN - India 115
CA - Canada 98
ZA - Sudafrica 79
AR - Argentina 70
BD - Bangladesh 67
IQ - Iraq 64
NL - Olanda 62
MX - Messico 51
EC - Ecuador 39
PK - Pakistan 38
JP - Giappone 30
MA - Marocco 29
TR - Turchia 28
VE - Venezuela 27
SA - Arabia Saudita 25
CL - Cile 24
CO - Colombia 23
ID - Indonesia 23
ES - Italia 22
KE - Kenya 22
PH - Filippine 19
EG - Egitto 18
PL - Polonia 18
UZ - Uzbekistan 18
GR - Grecia 16
MY - Malesia 16
RO - Romania 16
BE - Belgio 15
AT - Austria 14
TN - Tunisia 13
LT - Lituania 12
TH - Thailandia 12
CH - Svizzera 11
JO - Giordania 11
KZ - Kazakistan 10
PE - Perù 10
AE - Emirati Arabi Uniti 9
BO - Bolivia 9
IR - Iran 9
NP - Nepal 9
AZ - Azerbaigian 8
CZ - Repubblica Ceca 8
EU - Europa 8
IL - Israele 8
CR - Costa Rica 7
MU - Mauritius 7
DO - Repubblica Dominicana 6
MK - Macedonia 6
SI - Slovenia 6
UY - Uruguay 6
NI - Nicaragua 5
OM - Oman 5
AU - Australia 4
BH - Bahrain 4
DZ - Algeria 4
ET - Etiopia 4
HN - Honduras 4
JM - Giamaica 4
LV - Lettonia 4
NZ - Nuova Zelanda 4
PA - Panama 4
QA - Qatar 4
XK - ???statistics.table.value.countryCode.XK??? 4
AL - Albania 3
BG - Bulgaria 3
BN - Brunei Darussalam 3
RS - Serbia 3
TT - Trinidad e Tobago 3
BB - Barbados 2
BF - Burkina Faso 2
CI - Costa d'Avorio 2
DK - Danimarca 2
KG - Kirghizistan 2
KW - Kuwait 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
LK - Sri Lanka 2
MD - Moldavia 2
PY - Paraguay 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
SY - Repubblica araba siriana 2
YE - Yemen 2
AD - Andorra 1
AM - Armenia 1
Totale 23.757
Città #
Chandler 1.382
Jacksonville 1.324
Dublin 1.169
Nanjing 988
San Jose 864
Singapore 810
Ashburn 586
Dallas 584
Hong Kong 581
Munich 504
Boardman 465
Nanchang 452
Beijing 447
Princeton 358
Helsinki 311
Shenyang 303
Hebei 291
Lawrence 281
Changsha 265
Wilmington 259
Lauterbourg 246
Jiaxing 216
Hangzhou 185
Ho Chi Minh City 182
Los Angeles 180
Tianjin 158
Medford 142
Milan 133
Hanoi 124
Redondo Beach 106
Buffalo 91
Moscow 91
New York 79
Ann Arbor 74
Shanghai 69
Johannesburg 59
Seattle 58
Toronto 52
Norwalk 50
São Paulo 47
Woodbridge 47
Da Nang 37
Kunming 35
Baghdad 33
Santa Clara 33
Tokyo 30
Turku 29
Verona 28
Pavia 27
Guangzhou 26
Council Bluffs 25
Jinan 25
Orem 23
Des Moines 22
Frankfurt am Main 21
Brooklyn 20
Rome 20
Atlanta 19
Dhaka 19
Haiphong 19
Quito 19
Ningbo 18
Stockholm 18
Zhengzhou 18
Chennai 17
San Francisco 17
Chicago 16
Magenta 16
Nairobi 16
Tashkent 16
Brussels 15
Fairfield 15
Montreal 15
Houston 14
Jyväskylä 14
Warsaw 14
Mexico City 13
Redwood City 13
Lahore 12
Lanzhou 12
Phoenix 12
Vienna 12
Brasília 11
Jeddah 11
Rio de Janeiro 11
Caracas 10
Santiago 10
Timisoara 10
Vancouver 10
Amman 9
Boston 9
Casablanca 9
Delhi 9
Guayaquil 9
Mumbai 9
New Delhi 9
Ribeirão Preto 9
Riyadh 9
Amsterdam 8
Cape Town 8
Totale 15.606
Nome #
Effetto del lactobacillus paracasei I1688 e del lactobacillus salivarius I1794 (psmix®) sui lipidi ematici nell’ipercolesterolemia lieve 365
Impaired respiratory function reduces haemoglobin oxygen affinity in COVID-19 321
Antiproteinuric effect of telmisartan/amlodipine versus losartan/amlodipine combination in microalbuminuric hypertensive patients with type 2 diabetes 289
Anemia in patients with Covid-19: pathogenesis and clinical significance 286
Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study. 252
Atorvastatin addition to losartan or to atenolol and recurrence of paroxysmal atrial fibrillation in hypertension 248
Barnidipine or Lercanidipine on Echocardiographic Parameters in Hypertensive, Type 2 Diabetics with Left Ventricular Hypertrophy: A Randomized Clinical Trial 242
Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy 172
Correction to: Anemia in patients with Covid-19: pathogenesis and clinical significance (Clinical and Experimental Medicine, (2021), 10.1007/s10238-020-00679-4) 153
Correction to: Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy (Internal and Emergency Medicine, (2021), 16, 5, (1141-1152), 10.1007/s11739-020-02550-6) 149
Addition of Manidipine Improves the Antiproteinuric Effect of Candesartan in Hypertensive Patients With Type II Diabetes and Microalbuminuria. 145
Impact of COVID-19 on liver function: results from an internal medicine unit in Northern Italy 136
Is it really infective endocarditis? Distinguishing systemic vasculitis from its mimics 129
Antiproteinuric effect of telmisartan/amlodipine versus losartan/amlodipine combination in microalbuminuric hypertensive patients with type 2 diabetes 128
ACE inhibition but not angiotensin II antagonism reduces plasma fibrinogen and insulin resistance in overweight hypertensive patients 127
Comparison between diet, orlistat and fluvastatin in obese patients with mild hypertension and hypercholesterolemia 125
Atorvastatin-amlodipine combination and fibrinolytic balance in hypertensive hypercholesterolemic insulin-resistent patients 125
Effect of valsartan or olmesartan addition to amlodipine/hydrochlorotiazide combination on 24 hour blood pressure reduction in essential hypertension 123
Confronto tra dieta, orlistat e fluvastatina in soggetti obesi, con ipertensione arteriosa lieve e ipercolesterolemia 122
Effect on the development of ankle edema of adding delapril to manidipine inpatients with mild to moderate essential hypertension: a three-way crossoverstudy. 120
Effect of telmisartan-amlodipine combination at different doses on urinary albumin excretion in hypertensive diabetic patients with microalbuminuria 119
Actions of glimepiride plus metformin compared to rosiglitazone plus metformin on glucose metabolism, fibrinolytic, and coagulation measurements in Type 2 diabetic patients. 119
Effect of telmisartan/hydrochlorothiazide combination versus nifedipine GITS on ambulatory blood pressure and sympathetic activation. 118
Comparison between orlistat and sibutramine in obese patients with mild hypertension 117
Effect of valsartan amlodipine combination on left ventricular hypertrophy in hypertensive type 2 diabetic patients 117
Losartan and prevention of atrial fibrillation recurrence in hypertensive patients. 113
Atorvastatin addition to losartan or to atenolol and recurrence of paroxysmal atrial fibrillation in hypertension 113
Adding Losartan to Lisinopril Therapy in Patients with Hypertension: Assessment by 24-hour Ambulatory Blood Pressure Monitoring. 113
A study about the relevance of adding acetylsalicylic acid in primary prevention in subjects with type 2 diabetes mellitus: effects on some new emerging biomarkers of cardiovascular risk 112
Aliskiren reduces QT dispersion in hypertensive diabetic patients 111
Comparison between glimepiride plus pioglitazone vs. glimepiride plus rosiglitazone on glucose metabolism and on lipid, lipoprotein and apolipoprotein fractions in type 2 diabetic patients 110
Effects of valsartan compared with enalapril on blood pressure and cognitive function in elderly patients with essential hypertension 108
Effect of delapril-manidipine combination vs irbesartan-hydrochlorothiazide combination on fibrinolytic function in hypertensive patients with type II diabetes mellitus 108
Comparison of the effects of valsartan and felodipine on plasma leptin and insulin sensitivity in hypertensive obese patients 108
Beta-blockers effects on plasma lipids during prolonged treatment of hypertensive patients with hypercholesterolemia 108
Comparative effect of lercanidipine and nifedipine gastrointestinal therapeutic system on ankle volume and subcutaneous interstitial pressure in hypertensive patients:a double-blind, randomized, parallel-group study . 107
Effect of successful hypertension control by manidipine or lisinopril on albuminuria and left ventricular mass in diabetic hypertensive patients with microalbuminuria. 106
Comparison between fosinopril and eprosartan on lipid profile and Lp(a) in normotensive, type 2 diabetic subjects, with microalbuminuria 106
Comparison between orlistat and sibutramine in obese patients with type 2 diabetes mellitus 106
Effect of valsartan addition to amlodipine on ankle oedema and subcutaneous tissue pressure in hypertensive patients. 105
Changes during glimepiride plus rosiglitazone vs glibenclamide plus rosiglitazone treatment on glucose metabolism and lipoprotein (a) in Type 2 diabetic patients. 105
Effects of Amlodipine, Nifedipine GITS anf Indomethacin on Angiotensin-converting enzyme inhibitor-induced cough: a randomized, placebo-controlled, double-masked croossover study 104
Fixed combination of manidipine and delapril in the treatment of mild to moderate essential hypertension: evaluation by 24-hour ambulatory blood pressure monitoring 103
Effect of valsartan and ramipril on atrial fibrillation recurrence and P-wave dispersion in hypertensive patients with recurrent symptomatic lone atrial fibrillation 103
Effects of lisinopril vs hydralazine on left ventricular hypertrophy and ambulatory blood pressure monitoring in essential hypertension 102
Antiproteinuric effect of telmisartan/amlodipine versus losartan/amlodipine combination in microalbuminuric hypertensive patients with type 2 diabetes 102
Barnidipine compared to lercanidipine in addition to losartan on endothelial damage and oxidative stress parameters in patients with hypertension and type 2 diabetes mellitus 102
Effect of telmisartan and ramipril on atrial fibrillation recurrence and severity in hypertensive patients with metabolic syndrome and recurrent symptomatic paroxysmal and persistent atrial fibrillation 100
Effect of telmisartan/hydrochlorothiazide vs lisinopril/hydrochlorothiazide combination on ambulatory blood pressure and cognitive function in elderly hypertensive patients. 99
Olmesartan-associated enteropathy: New insights on the natural history? Report of two cases 99
A double-blind, crossover study of the antihypertensive efficacy of angiotensinII-receptor antagonists and their activation of the renin-angiotensin system. 99
Comparative Efficacy of Losartan and Valsartan in Mild-to-Moderate Hypertension : results of 24-Hour Ambulatory Blood Pressure Monitoring. 99
Confronto tra l'effetto anti-proteinurico dell'associazione telmisartan/amlodipina rispetto a losartan/amlodipina nel paziente con diabete di tipo 2, iperteso e microalbuminurico 97
Perindopril and candesartan comparative efficacy and safety in type II diabetic hypertensive patients. 97
Efficacy of Delapril in the treatment of mild to moderate essential hypertension : evaluation by 24-hour ambulatory blood pressure monitoring. 97
Efficacy of fluvastatin together with fenofibrate in hypercholesterolemic type 2 diabetic subjects compared to monotherapy. 97
Ambulatory blood pressure parameters after canrenone addition to existing treatment regimens with maximum tolerated dose of angiotensin-converting enzyme inhibitors/angiotensin II type 1 receptor blockers plus hydrochlorothiazide in uncontrolled hypertensive patients 96
Effect of Valsartan and Atenolol on sexual behavior in hypertensive postmenopausal women. 95
Fixed combination of benazepril and low-dose amlodipine in the treatment of mild to moderate essential hypertension: evaluation by 24-hour noninvasive ambulatory blood pressure monitoring 95
Effects of valsartan or ramipril addition to amlodipine/hydrochlorothiazide combination on left ventricular mass in diabetic hypertensive patients with left ventricular hypertrophy 95
Comparison between repaglinide plus metformin vs glimepiride plus metformin on glucose metabolism, fibrinolytic, and coagulation measurements in Type 2 diabetic patients: a 1 year 95
Effect of losartan irbesartan and candesartan on platelet aggregability and fibrinolysis in type 2 diabetic hypertensive patients 93
Effect of manidipine-rosuvastatin combination on fibrinolysis, inflammation markers and insulin sensitivity in hypertensive hypercholesterolemic patients 92
Effects of valsartan and olmesartan Addition to amlodipine on ankle oedema in hypertensive patients 91
Effect of valsartan or ramipril addition to amlodipine/hydrochlorotiazide combination on left ventricular hypertrophy in hypertensive patients with type 2 diabetes 91
Different effects of aliskiren/hydrochlorotiazide and atenol/hydrochlorotiazide combinations on central pressure in elderly hypertensive patients 91
Effects of four angiotensin II-receptor antagonists on fibrinolysis in postmenopausal women with hypertension. 91
Effetto della combinazione valsartan-amlodipina sulla funzione cognitiva in pazienti ipertesi anziani 91
Effect of antihypertensive treatment with valsartan or atenolol on sexual activity and plasma testosterone in hypertensive men 90
Effect of losartan irbesartan and candesartan on platelet aggregability and fibrinolysis in type 2 diabetic hypertensive patients 90
Effect of valsartan on insulin sensitivity and leptin in hypertensive obese patients 90
Effects of different dihydropyridine calcium antagonists on plasma norepinephrine in essential hypertension. 90
Effect of delapril-manidipine combination vs irbesartan-hydrochlorothiazide combination on fibrinolytic function in hypertensive patients with type II diabetes mellitus 89
Valsartan amlodipine combination and prevention of atrial fibrillation recurrence in hypertensive diabetic patients 89
Effect of valsartan addition to amlodipine on ankle oedema and subcutaneous tissue pressure in hypertensive patients 89
Comparative effects of nebivolol and atenolol on blood pressure and insulin sensitivity in hypertensive subjects with type II diabetes 89
Effect of aliskiren addition to losartan on fibrinolysis in diabetic hypertensive patients: a three-way crossover study. 89
Comparison between glimepiride plus metformin vs rosiglitazone plus metformin on glucose metabolism and on blood pressure in Type 2 diabetic patients 89
Comparison between diet, orlistat and cerivastatin in hypercholesterolemic, obese patients, with mild hypertension 88
Effects of aliskiren on QT duration and dispersion in hypertensive patients with type 2 diabetes mellitus. 88
Matrix metalloproteinase 2 and 9 evaluation in patients with or without diabetes during acute coronary syndrome and after the acute event 87
Effects of different dihydropyridine calcium antagonists on plasma norepinephrine in essential hypertension 87
Different effects of aliskiren and losartan on fibrinolysis and insulin sensitivity in hypertensive patients with metabolic syndrome 87
Comparison of benazepril-amlodipine and captopril-thiazide in the management of mild-to-moderate hypertension. 87
Effects of amlodipine-atorvastatin combination on fibrinolysis in hypertensive hypercholesterolemic patients with insulin resistance. 87
Long-term effects of Amlodipine versus Fosinopril on microalbuminuria in elderly hypertensive patients with type 2 Diabetes Mellitus. 87
Comparison between perindopril and candesartan in hypertensive patients with type 2 diabetes: evaluation of lipid profile and Lp(a) 87
Effects of manidipine/delapril versus olmesartan/hydrochlorothiazide combination therapy in elderly hypertensive patients with type 2 diabetes mellitus. 86
Effects of valsartan versus olmesartan addition to amlodipine/hydrochlorothiazide combination in treating stage 2 hypertensive patients 86
Losartan and amlodipine on myocardial structure and function: a prospective, randomized, clinical trial 85
Lone paroxysmal atrial fibrillation and inflammatory markers in essential hypertension 85
Effect of telmisartan and ramipril on arial fibrillation episodes recurrence and severity in hypertensive patients with metabolic syndrome and lone paroxysmal atrial fibrillation 85
Time course of antiproteinuric effect of aliskiren in arterial hypertension associated with type 2 diabetes and microalbuminuria 85
Effect of naproxen and acetaminophen on blood pressure lowering by ramipril, valsartan and aliskiren in hypertensive patients 85
Ambulatory monitoring of systolic hypertension in the elderly: Eprosartan/hydrochlorothiazide compared with losartan/hydrochlorothiazide (INSIST trial). 85
Effect of valsartan compared to losartan on insulin-resisstance parameters in overweight hypertensive patients 85
Efficacia di fluvastatina e fenofibrato in prevenzione secondaria rispetto alla monoterapia: studio ad 1 anno in pazienti diabetici di tipo 2, ipercolesterolemici 84
Effetti dell'associazione valsartan-amlodipina sui marcatori dell'infiammazione, sullo stress ossidativo e sulla dimetilarginina asimmetrica nei pazienti ipertesi con diabete di tipo 2 84
Ketanserin effects on insulin sensitivity in nonobese, nondiabetic hypertensive patients: an evaluation by the euglycemic-hyperinsulinemic clamp technique. 84
Effect of losartan irbesartan and candesartan on platelet aggregability and fibrinolysis in type 2 diabetic hypertensive patients 83
Totale 11.483
Categoria #
all - tutte 90.786
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 90.786


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021636 0 0 0 0 0 0 0 0 0 294 272 70
2021/20221.057 21 2 49 6 6 15 16 76 65 25 185 591
2022/20233.771 388 218 25 325 485 443 2 240 1.426 46 117 56
2023/20241.097 112 194 38 69 196 250 35 103 14 39 16 31
2024/20253.623 42 314 95 134 67 203 379 415 819 57 307 791
2025/20266.562 562 531 777 614 738 350 1.663 306 627 394 0 0
Totale 23.883